Skip to Main Content

Paper Details

Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.
Antiviral Res
5
2023
373, BA.1, BA.2, COVID-19, Calu-, N-0385, Omicron, Omicron subvariant BA.2, PKC, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 virus, V-ATPase, alotaketal C, bafilomycin D, holyrine A, human, human Calu-3 lung cells, human TMPRSS2 protease, human V-ATPase, lung epithelial cell line, mNG, mNG-, mNeonGreen, mNeonGreen (mNG) reporter, monoclonal, protein kinase C, severe, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Guangping GaoLife Sciences Institute, University of British Columbia
Xuping XieUniversity of Texas Medical Branch
Pei-Yong ShiUniversity of Texas Medical Branch
  • 1 - 3

Datasets

Release 1.2